Yahoo Finance's Anjalee Khemlani joins the Live show to discuss the FDA's authorization of broader access to Pfizer’s COVID-19 pill.
The semiconductor market is expanding at a compounded annual growth rate (CAGR) of more than 9%, per estimates from Fortune Business Insights. Insight Partners projects the cloud computing business to be even more promising, with its CAGR up around 24%. Analysts at Grand View Research say this sector could grow at a ridiculous CAGR of 104.2% until 2028.
This should be especially good news for Moderna (NASDAQ: MRNA). The first hurdle is that Moderna must obtain FDA Emergency Use Authorization (EUA) for its omicron booster. The second hurdle for Moderna is to secure an additional supply deal with the U.S. government that includes omicron boosters.